BAM
LUCD icon

Byrne Asset Management’s Lucid Diagnostics LUCD Stock Holding History

Byrne Asset Management’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,000
Closed -$9.56K – 553
2024
Q2 		$9.56K Buy
+11,000
New +$9.32K 0.01% 379
2024
Q1 		– Sell
-6,610
Closed -$9.52K – 558
2023
Q4 		$9.52K Sell
6,610
-600
-8% -$791 0.01% 364
2023
Q3 		$8K Buy
+7,210
New +$10.5K 0.01% 358

Other funds holding LUCD

LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Byrne Asset Management's LUCD Position: Q3 2024 in Review

Byrne Asset Management sold out of Lucid Diagnostics (LUCD) in Q3 2024, closing a stake of 11,000 shares — an estimated $9.56K sold.

Byrne Asset Management first reported a position in LUCD in Q3 2023 and held it in 3 quarters. The position peaked at $9.56K in Q2 2024. 29 funds tracked by Wall St. Rank hold LUCD as of Q3 2024.

  • Byrne Asset Management reported no remaining Lucid Diagnostics position as of Q3 2024 after selling out during the quarter.
  • Byrne Asset Management sold 11,000 Lucid Diagnostics shares in Q3 2024, an estimated $9.56K.
  • Byrne Asset Management first reported a position in Lucid Diagnostics in Q3 2023 and held it in 3 quarters.
  • Byrne Asset Management's Lucid Diagnostics position peaked at $9.56K in Q2 2024.
  • 29 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q3 2024.

Based on Byrne Asset Management's 13F filing for Q3 2024, filed 28 Jan 2025.